0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Digital Therapeutics for Endocrine System Diseases Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-32P12868
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Digital Therapeutics for Endocrine System Diseases Market Research Report 2023
BUY CHAPTERS

Global Digital Therapeutics for Endocrine System Diseases Market Research Report 2025

Code: QYRE-Auto-32P12868
Report
April 2025
Pages:70
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Digital Therapeutics for Endocrine System Diseases Market

The global market for Digital Therapeutics for Endocrine System Diseases was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Digital Therapeutics for Endocrine System Diseases are software program-driven, evidence-based interventions to treat, manage, or prevent endocrine system diseases.
North American market for Digital Therapeutics for Endocrine System Diseases is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Digital Therapeutics for Endocrine System Diseases is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Digital Therapeutics for Endocrine System Diseases in Diabetes is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Digital Therapeutics for Endocrine System Diseases include Livongo, SHANGYI, EnteroMedics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Digital Therapeutics for Endocrine System Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Therapeutics for Endocrine System Diseases.
The Digital Therapeutics for Endocrine System Diseases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Digital Therapeutics for Endocrine System Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Digital Therapeutics for Endocrine System Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Digital Therapeutics for Endocrine System Diseases Market Report

Report Metric Details
Report Name Digital Therapeutics for Endocrine System Diseases Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Livongo, SHANGYI, EnteroMedics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Digital Therapeutics for Endocrine System Diseases company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Digital Therapeutics for Endocrine System Diseases Market report?

Ans: The main players in the Digital Therapeutics for Endocrine System Diseases Market are Livongo, SHANGYI, EnteroMedics

What are the Application segmentation covered in the Digital Therapeutics for Endocrine System Diseases Market report?

Ans: The Applications covered in the Digital Therapeutics for Endocrine System Diseases Market report are Diabetes, Metabolic Syndrome, Obesity, Other

What are the Type segmentation covered in the Digital Therapeutics for Endocrine System Diseases Market report?

Ans: The Types covered in the Digital Therapeutics for Endocrine System Diseases Market report are Prevention, Management, Treatment

Recommended Reports

Endocrine Disease Treatments

Digital Therapeutics

Diabetes and Metabolism

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prevention
1.2.3 Management
1.2.4 Treatment
1.3 Market by Application
1.3.1 Global Digital Therapeutics for Endocrine System Diseases Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diabetes
1.3.3 Metabolic Syndrome
1.3.4 Obesity
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Digital Therapeutics for Endocrine System Diseases Market Perspective (2020-2031)
2.2 Global Digital Therapeutics for Endocrine System Diseases Growth Trends by Region
2.2.1 Global Digital Therapeutics for Endocrine System Diseases Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Digital Therapeutics for Endocrine System Diseases Historic Market Size by Region (2020-2025)
2.2.3 Digital Therapeutics for Endocrine System Diseases Forecasted Market Size by Region (2026-2031)
2.3 Digital Therapeutics for Endocrine System Diseases Market Dynamics
2.3.1 Digital Therapeutics for Endocrine System Diseases Industry Trends
2.3.2 Digital Therapeutics for Endocrine System Diseases Market Drivers
2.3.3 Digital Therapeutics for Endocrine System Diseases Market Challenges
2.3.4 Digital Therapeutics for Endocrine System Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Digital Therapeutics for Endocrine System Diseases Players by Revenue
3.1.1 Global Top Digital Therapeutics for Endocrine System Diseases Players by Revenue (2020-2025)
3.1.2 Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Players (2020-2025)
3.2 Global Digital Therapeutics for Endocrine System Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Digital Therapeutics for Endocrine System Diseases Revenue
3.4 Global Digital Therapeutics for Endocrine System Diseases Market Concentration Ratio
3.4.1 Global Digital Therapeutics for Endocrine System Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Therapeutics for Endocrine System Diseases Revenue in 2024
3.5 Global Key Players of Digital Therapeutics for Endocrine System Diseases Head office and Area Served
3.6 Global Key Players of Digital Therapeutics for Endocrine System Diseases, Product and Application
3.7 Global Key Players of Digital Therapeutics for Endocrine System Diseases, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Digital Therapeutics for Endocrine System Diseases Breakdown Data by Type
4.1 Global Digital Therapeutics for Endocrine System Diseases Historic Market Size by Type (2020-2025)
4.2 Global Digital Therapeutics for Endocrine System Diseases Forecasted Market Size by Type (2026-2031)
5 Digital Therapeutics for Endocrine System Diseases Breakdown Data by Application
5.1 Global Digital Therapeutics for Endocrine System Diseases Historic Market Size by Application (2020-2025)
5.2 Global Digital Therapeutics for Endocrine System Diseases Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Digital Therapeutics for Endocrine System Diseases Market Size (2020-2031)
6.2 North America Digital Therapeutics for Endocrine System Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2020-2025)
6.4 North America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Digital Therapeutics for Endocrine System Diseases Market Size (2020-2031)
7.2 Europe Digital Therapeutics for Endocrine System Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Digital Therapeutics for Endocrine System Diseases Market Size by Country (2020-2025)
7.4 Europe Digital Therapeutics for Endocrine System Diseases Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size (2020-2031)
8.2 Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size by Region (2020-2025)
8.4 Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Digital Therapeutics for Endocrine System Diseases Market Size (2020-2031)
9.2 Latin America Digital Therapeutics for Endocrine System Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2020-2025)
9.4 Latin America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size (2020-2031)
10.2 Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size by Country (2020-2025)
10.4 Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Livongo
11.1.1 Livongo Company Details
11.1.2 Livongo Business Overview
11.1.3 Livongo Digital Therapeutics for Endocrine System Diseases Introduction
11.1.4 Livongo Revenue in Digital Therapeutics for Endocrine System Diseases Business (2020-2025)
11.1.5 Livongo Recent Development
11.2 SHANGYI
11.2.1 SHANGYI Company Details
11.2.2 SHANGYI Business Overview
11.2.3 SHANGYI Digital Therapeutics for Endocrine System Diseases Introduction
11.2.4 SHANGYI Revenue in Digital Therapeutics for Endocrine System Diseases Business (2020-2025)
11.2.5 SHANGYI Recent Development
11.3 EnteroMedics
11.3.1 EnteroMedics Company Details
11.3.2 EnteroMedics Business Overview
11.3.3 EnteroMedics Digital Therapeutics for Endocrine System Diseases Introduction
11.3.4 EnteroMedics Revenue in Digital Therapeutics for Endocrine System Diseases Business (2020-2025)
11.3.5 EnteroMedics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Prevention
 Table 3. Key Players of Management
 Table 4. Key Players of Treatment
 Table 5. Global Digital Therapeutics for Endocrine System Diseases Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Digital Therapeutics for Endocrine System Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Digital Therapeutics for Endocrine System Diseases Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Digital Therapeutics for Endocrine System Diseases Market Share by Region (2020-2025)
 Table 9. Global Digital Therapeutics for Endocrine System Diseases Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Digital Therapeutics for Endocrine System Diseases Market Share by Region (2026-2031)
 Table 11. Digital Therapeutics for Endocrine System Diseases Market Trends
 Table 12. Digital Therapeutics for Endocrine System Diseases Market Drivers
 Table 13. Digital Therapeutics for Endocrine System Diseases Market Challenges
 Table 14. Digital Therapeutics for Endocrine System Diseases Market Restraints
 Table 15. Global Digital Therapeutics for Endocrine System Diseases Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Digital Therapeutics for Endocrine System Diseases Market Share by Players (2020-2025)
 Table 17. Global Top Digital Therapeutics for Endocrine System Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics for Endocrine System Diseases as of 2024)
 Table 18. Ranking of Global Top Digital Therapeutics for Endocrine System Diseases Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Digital Therapeutics for Endocrine System Diseases Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Digital Therapeutics for Endocrine System Diseases, Headquarters and Area Served
 Table 21. Global Key Players of Digital Therapeutics for Endocrine System Diseases, Product and Application
 Table 22. Global Key Players of Digital Therapeutics for Endocrine System Diseases, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Digital Therapeutics for Endocrine System Diseases Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Type (2020-2025)
 Table 26. Global Digital Therapeutics for Endocrine System Diseases Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Type (2026-2031)
 Table 28. Global Digital Therapeutics for Endocrine System Diseases Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Application (2020-2025)
 Table 30. Global Digital Therapeutics for Endocrine System Diseases Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Application (2026-2031)
 Table 32. North America Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Digital Therapeutics for Endocrine System Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Digital Therapeutics for Endocrine System Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Livongo Company Details
 Table 48. Livongo Business Overview
 Table 49. Livongo Digital Therapeutics for Endocrine System Diseases Product
 Table 50. Livongo Revenue in Digital Therapeutics for Endocrine System Diseases Business (2020-2025) & (US$ Million)
 Table 51. Livongo Recent Development
 Table 52. SHANGYI Company Details
 Table 53. SHANGYI Business Overview
 Table 54. SHANGYI Digital Therapeutics for Endocrine System Diseases Product
 Table 55. SHANGYI Revenue in Digital Therapeutics for Endocrine System Diseases Business (2020-2025) & (US$ Million)
 Table 56. SHANGYI Recent Development
 Table 57. EnteroMedics Company Details
 Table 58. EnteroMedics Business Overview
 Table 59. EnteroMedics Digital Therapeutics for Endocrine System Diseases Product
 Table 60. EnteroMedics Revenue in Digital Therapeutics for Endocrine System Diseases Business (2020-2025) & (US$ Million)
 Table 61. EnteroMedics Recent Development
 Table 62. Research Programs/Design for This Report
 Table 63. Key Data Information from Secondary Sources
 Table 64. Key Data Information from Primary Sources
 Table 65. Authors List of This Report


List of Figures
 Figure 1. Digital Therapeutics for Endocrine System Diseases Picture
 Figure 2. Global Digital Therapeutics for Endocrine System Diseases Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Digital Therapeutics for Endocrine System Diseases Market Share by Type: 2024 VS 2031
 Figure 4. Prevention Features
 Figure 5. Management Features
 Figure 6. Treatment Features
 Figure 7. Global Digital Therapeutics for Endocrine System Diseases Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Digital Therapeutics for Endocrine System Diseases Market Share by Application: 2024 VS 2031
 Figure 9. Diabetes Case Studies
 Figure 10. Metabolic Syndrome Case Studies
 Figure 11. Obesity Case Studies
 Figure 12. Other Case Studies
 Figure 13. Digital Therapeutics for Endocrine System Diseases Report Years Considered
 Figure 14. Global Digital Therapeutics for Endocrine System Diseases Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Digital Therapeutics for Endocrine System Diseases Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Digital Therapeutics for Endocrine System Diseases Market Share by Region: 2024 VS 2031
 Figure 17. Global Digital Therapeutics for Endocrine System Diseases Market Share by Players in 2024
 Figure 18. Global Top Digital Therapeutics for Endocrine System Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics for Endocrine System Diseases as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Digital Therapeutics for Endocrine System Diseases Revenue in 2024
 Figure 20. North America Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Digital Therapeutics for Endocrine System Diseases Market Share by Country (2020-2031)
 Figure 22. United States Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Digital Therapeutics for Endocrine System Diseases Market Share by Country (2020-2031)
 Figure 26. Germany Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Share by Region (2020-2031)
 Figure 34. China Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Digital Therapeutics for Endocrine System Diseases Market Share by Country (2020-2031)
 Figure 42. Mexico Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Share by Country (2020-2031)
 Figure 46. Turkey Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Livongo Revenue Growth Rate in Digital Therapeutics for Endocrine System Diseases Business (2020-2025)
 Figure 50. SHANGYI Revenue Growth Rate in Digital Therapeutics for Endocrine System Diseases Business (2020-2025)
 Figure 51. EnteroMedics Revenue Growth Rate in Digital Therapeutics for Endocrine System Diseases Business (2020-2025)
 Figure 52. Bottom-up and Top-down Approaches for This Report
 Figure 53. Data Triangulation
 Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Liraglutide Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11A9578
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Diabetes Care Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I8272
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Thyroid Gland Disorder Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16N11302
Mon Sep 08 00:00:00 UTC 2025

Add to Cart